Seeking Alpha

ATHX
  Athersys, Inc. - NASDAQ

10/21/2014, 11:16 PM ET
  • Robbster | Send Message 19 Jan

    Dev Biotech Portfolio update: stem cell 51% ($ATHX $NBS $CUR $PSTI $SCTPF $STEM) Device 16% ($ONCS $EDAP) Immuno 9% ($NWBO $IMUC) Misc 24%
    Reply (16)
  • View all 16 replies
    • Robbster | Send Message 21 Jan
      : Regarding $MNKD, have done DD, not a supporter, as the oral insulin increases insulin resistance vs. injection/pump. Serious issue.
    • Robbster | Send Message 21 Jan
      : $CHTP headed for possible approval in couple weeks, so you're riding the sentiment up to that news. Have done before, but only with DD.
      ATHX vs. ETF Alternatives
      Company Description
      Athersys Inc is a biopharmaceutical company developing regenerative medicine. It is engaged in the discovery and development of therapies designed to extend and enhance human life.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States